for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Masimo Corporation

MASI.OQ

Latest Trade

151.98USD

Change

0.48(+0.32%)

Volume

312,868

Today's Range

150.52

 - 

152.65

52 Week Range

98.38

 - 

160.21

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
151.50
Open
151.60
Volume
312,868
3M AVG Volume
7.38
Today's High
152.65
Today's Low
150.52
52 Week High
160.21
52 Week Low
98.38
Shares Out (MIL)
53.33
Market Cap (MIL)
8,078.87
Forward P/E
48.10
Dividend (Yield %)
--

Next Event

Q3 2019 Masimo Corp Earnings Release

Latest Developments

More

Masimo Q2 Non-GAAP Earnings Per Share $0.76

Masimo Q1 GAAP Earnings Per Share $0.87

Masimo Reports First Quarter 2019 Financial Results

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company's business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive monitoring of blood constituents with an optical signature, optical organ oximetry monitoring, electrical, brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. In addition, the Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor, and the Radius-7 wearable wireless patient monitor. It offers Patient SafetyNet remote patient surveillance monitoring system, which allows patients to be monitored through a personal computer-based monitor or by care providers through their pagers, voice-over-Internet Protocol (IP) phones or smartphones.

Industry

Medical Equipment & Supplies

Contact Info

52 Discovery

+1.949.2977000

http://www.masimo.com/

Executive Leadership

Joseph E. Kiani

Chairman of the Board, Chief Executive Officer

Micah W. Young

Chief Financial Officer, Executive Vice President - Finance

Jon Coleman

President - Worldwide Sales, Professional Services and Medical Affairs

Anand Sampath

Chief Operating Officer

Yongsam Lee

Executive Vice President, Chief Information Officer

Key Stats

2.14 mean rating - 7 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.7K

2017

0.8K

2018

0.9K

2019(E)

0.9K
EPS (USD)

2016

2.280

2017

3.130

2018

3.030

2019(E)

3.150
Price To Earnings (TTM)
42.70
Price To Sales (TTM)
9.03
Price To Book (MRQ)
7.77
Price To Cash Flow (TTM)
36.49
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
20.20
Return on Equity (TTM)
17.81

Latest News

BRIEF-Masimo Q1 GAAP Earnings Per Share $0.82

* Q1 EARNINGS PER SHARE VIEW $0.69 -- THOMSON REUTERS I/B/E/S

BRIEF-Masimo Announces CE Marking Of Rad-97 Pulse CO-Oximeter With Integrated NomoLine Capnography

* MASIMO ANNOUNCES CE MARKING OF RAD-97™ PULSE CO-OXIMETER® WITH INTEGRATED NOMOLINE™ CAPNOGRAPHY

BRIEF-Masimo Corp Q4 GAAP Earnings Per Share $0.01

* QTRLY TOTAL REVENUE, INCLUDING ROYALTY AND OTHER REVENUE, INCREASED 22.9% TO $225.2 MILLION Source text for Eikon: Further company coverage:

BRIEF-Masimo Corp‍ Announced FDA Clearance Of Next Generation Sedline Brain Function Monitoring​

* MASIMO CORP - ANNOUNCED FDA CLEARANCE OF NEXT GENERATION SEDLINE BRAIN FUNCTION MONITORING Source text for Eikon: Further company coverage:

BRIEF-Masimo Announces FDA Clearance For Home Use Of Rad-97

* MASIMO ANNOUNCES FDA CLEARANCE FOR HOME USE OF RAD-97™ Source text for Eikon: Further company coverage:

BRIEF-Masimo ‍announces FDA clearance and U.S. release Of full family of NomoLine capnography sampling lines​

* ANNOUNCES FDA CLEARANCE AND U.S. RELEASE OF FULL FAMILY OF NOMOLINE CAPNOGRAPHY SAMPLING LINES Source text for Eikon: Further company coverage:

BRIEF-‍San Diego bankruptcy court issues final judgment on Masimo Corp

* Masimo Corp - Bankruptcy court in San Diego has issued final judgment, holding that "Sotera Wireless employees misappropriated Masimo trade secrets" Source text for Eikon: Further company coverage:

BRIEF-Masimo reports FDA clearance and full market release of rad-97 pulse co-oximeter

* Masimo announces FDA clearance and full market release of rad-97™ pulse co-oximeter® Source text for Eikon: Further company coverage:

BRIEF-Masimo says CFO Mark De Raad to retire

* Masimo Corp - On August 23, Mark P. De Raad, CFO, notified co of his intention to retire and resign from his roles with the company

BRIEF-Dubai Health Authority implementiert Masimo Patient SafetyNet

* Dubai Health Authority implementiert Masimo Patient SafetyNet Source text for Eikon: Further company coverage:

BRIEF-Masimo Q2 earnings per share $0.83

* Q2 earnings per share view $0.71 -- Thomson Reuters I/B/E/S

BRIEF-Masimo Corp says appears co addressed violations contained in FDA warning letter regarding Irvine facility

* Masimo - on May 26, received letter from FDA indicating FDA has completed an evaluation of Masimo's corrective actions in response to warning letter

BRIEF-Masimo CEO Joe Kiani's total compensation in 2016 was $9 mln

* CEO Joe Kiani's total compensation in 2016 was $9 million versus $7.3 million in 2015- SEC filing Source text: [http://bit.ly/2nDDlhw] Further company coverage:

BRIEF-Masimo reports ce marking of rad-97(tm) pulse co-oximeter®

* Masimo announces ce marking of rad-97(tm) pulse co-oximeter® and connectivity hub with noninvasive blood pressure Source text for Eikon: Further company coverage:

BRIEF-Masimo announces CE marking of respiration rate measurement on MightySat Rx

* Masimo announces CE marking of respiration rate measurement on MightySat Rx Source text for Eikon: Further company coverage:

BRIEF-Masimo Q4 earnings per share $3.97

* Masimo reports fourth quarter and fiscal year 2016 financial results

BRIEF-Masimo and Philips to end all pending lawsuits

* Philips and Masimo corporation announced a wide-ranging, multi-year business partnership involving both companies' innovations in patient monitoring and therapy solutions

BRIEF-Adam Mikkelson joins Masimo's board of directors

* Adam Mikkelson of Camber Capital Management joins Masimo's board of directors Source text for Eikon: Further company coverage:

BRIEF-Masimo announces CE marking of Rad-97(TM) pulse co-oximeter

* Masimo announces CE marking of Rad-97(TM) pulse co-oximeter Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up